EXCRETION OF 3 MAJOR PROSTATIC SECRETORY PROTEINS IN THE URINE OF NORMAL MEN AND PATIENTS WITH BENIGN PROSTATIC HYPERTROPHY OR PROSTATE-CANCER

被引：51

作者：

TREMBLAY, J

FRENETTE, G

TREMBLAY, RR

DUPONT, A

THABET, M

DUBE, JY

机构：

[1] CHU LAVAL,HORMONAL & MOLEC REGULAT TISSULAR PROT LAB,2705 LAURIER BLVD,STE FOY G1V 4G2,QUEBEC,CANADA

[2] LAVAL HOSP,DEPT UROL,QUEBEC CITY,QUEBEC,CANADA

[3] CHU LAVAL,MOLEC ENDOCRINOL LAB,STE FOY G1V 4G2,QUEBEC,CANADA

来源：

PROSTATE | 1987年 / 10卷 / 03期

关键词：

D O I：

10.1002/pros.2990100306

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：235 / 243

页数：9

共 13 条

[1]

BENTZ MS, 1982, ARCH PATHOL LAB MED, V106, P476

[2]

DUBE JY, IN PRESS J ANDROLOGY

[3] IMMUNOHISTOCHEMICAL LOCALIZATION OF PROSTATE-SPECIFIC ACID-PHOSPHATASE AND PROSTATE-SPECIFIC ANTIGEN IN STAGE A2 ADENOCARCINOMA OF THE PROSTATE - PROGNOSTIC IMPLICATIONS [J].

EPSTEIN, JI ;

EGGLESTON, JC .

HUMAN PATHOLOGY, 1984, 15 (09) :853-859

[4] DETECTION OF PROSTATIC CANCER BY SOLID-PHASE RADIOIMMUNOASSAY OF SERUM PROSTATIC ACID-PHOSPHATASE [J].

FOTI, AG ;

COOPER, JF ;

HERSCHMAN, H ;

MALVAEZ, RR .

NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (25) :1357-1361

[5] PREDICTION OF PROGNOSIS FOR PROSTATIC ADENOCARCINOMA BY COMBINED HISTOLOGICAL GRADING AND CLINICAL STAGING [J].

GLEASON, DF ;

MELLINGE.GT .

JOURNAL OF UROLOGY, 1974, 111 (01) :58-64

[6] CHANGES IN IMMUNOHISTOCHEMICAL STAINING IN PROSTATIC ADENOCARCINOMA FOLLOWING DIETHYLSTILBESTROL THERAPY [J].

GRIGNON, D ;

TROSTER, M .

PROSTATE, 1985, 7 (02) :195-202

[7]

KENT JR, 1970, CANCER, V25, P858, DOI 10.1002/1097-0142(197004)25:4<858::AID-CNCR2820250415>3.0.CO

[8]

2-G

[9]

KURIYAMA M, 1980, Cancer Research, V40, P4658

[10]

KURIYAMA M, 1982, J NATL CANCER I, V68, P99

← 1 2 →